Clinical Trial Update: Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer. [Phase 3]

View source ↗

Summary

Phase 3 trial exploring camrelizumab in combination with apatinib, etoposide, and cisplatin for small-cell lung cancer is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Neoplasm
• Small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)
• CISPLATIN (cisplatin)
• Camrelizumab (camrelizumab)
• Etoposide (Etoposide)

Snippet

Sponsor: Fuzhou General Hospital | Conditions: Lung Neoplasm, Small Cell Lung Cancer | Phase 3 | Status: UNKNOWN